Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

The Effect of PPARalpha, PPARdelta, PPARgamma, and PPARpan Agonists on Body Weight, Body Mass, and Serum Lipid Profiles in Diet-Induced Obese AKR/J Mice.

Harrington WW, S Britt C, G Wilson J, O Milliken N, G Binz J, C Lobe D, R Oliver W, C Lewis M, M Ignar D.

PPAR Res. 2007;2007:97125.

2.
3.

PPAR dual agonists: are they opening Pandora's Box?

Balakumar P, Rose M, Ganti SS, Krishan P, Singh M.

Pharmacol Res. 2007 Aug;56(2):91-8. Epub 2007 Mar 14. Review.

PMID:
17428674
4.

Roles of peroxisome proliferator-activated receptor delta (PPARdelta) in the control of fatty acid catabolism. A new target for the treatment of metabolic syndrome.

Luquet S, Lopez-Soriano J, Holst D, Gaudel C, Jehl-Pietri C, Fredenrich A, Grimaldi PA.

Biochimie. 2004 Nov;86(11):833-7. Review.

PMID:
15589693
5.

Roles of PPAR delta in lipid absorption and metabolism: a new target for the treatment of type 2 diabetes.

Luquet S, Gaudel C, Holst D, Lopez-Soriano J, Jehl-Pietri C, Fredenrich A, Grimaldi PA.

Biochim Biophys Acta. 2005 May 30;1740(2):313-7. Epub 2004 Dec 8. Review.

6.

Role of PPAR- gamma agonist thiazolidinediones in treatment of pre-diabetic and diabetic individuals: a cardiovascular perspective.

Dumasia R, Eagle KA, Kline-Rogers E, May N, Cho L, Mukherjee D.

Curr Drug Targets Cardiovasc Haematol Disord. 2005 Oct;5(5):377-86. Review.

PMID:
16248830

Supplemental Content

Support Center